“…It is, however, noteworthy, that one single initial application may induce a prolonged beneficial effect in ischemia/reperfusion injuries in rat colitis (Duzel et al., ). Nevertheless, considering the chances of approval of this drug for apicultural use in the EU, these findings seem to be favorable with respect to several other alternative products that have been evaluated as possible treatments to control nosemosis in field conditions, for example preparations with the herbal basis (Bekesi, Szalai Matray, Harka, Hegedus, & Albert, ; Chioveanu, Ionescu, & Mardare, ; Maistrello et al., ; Nanetti, ; Tlak Gajger et al., ; Tlak Gajger, Vugrek, Pinter, & Petrinec, ; Tlak Gajger, Petrinec, Pinter, & Kozarić, ), mineral compounds (Tlak Gajger et al., ) or animal lysozymes and essential oils extracted from Vetiveria zizanioides (Maistrello et al., ), with varying effects which were similar or less effective in comparison with BPC 157.…”